On the afternoon of March 18, 2022, more than 30 alumni from the Hubei Branch of the CEIBS Alumni Association came to Wuhan Emerson Life Technology Co., Ltd. for a visit and exchange.

△ Group photo of alumni of CEIBS Alumni Association Hubei Branch

First of all, Dr. Zhang Lianglu, chairman and general manager of Emerson and a CEIBS alumnus, extended a warm welcome to the alumni. Immediately afterwards, Dr. Xiong Youhui, President of the Hubei Branch of the CEIBS Alumni Association, delivered a speech to express his wishes. He introduced more than 30 alumni to get to know each other and communicate with each other.

△ Dr. Xiong Youhui, President of CEIBS Alumni Association Hubei Branch

Next, Dr. Zhang Lianglu shared his entrepreneurial experience and the company's development path. Dr. Dong Lanlan, co-founder of Emerson, gave a detailed description of the company's field of early tumor screening and diagnosis, the company's core technology platform and representative products. introduce.

△ Dr. Zhang Lianglu, Chairman and General Manager of Emerson and CEIBS alumnus

△Dr. Lanlan Dong, co-founder of Emison

In the free exchange session, the alumni started exchanges and discussions, and the big coffees collided with each other and merged their ideas.

△ free exchange session

Finally, the alumni visited Emerson's corporate exhibition hall, manufacturing center, R&D center and medical laboratory, and recognized Emerson's great determination to strive for the development of human health and its leading technological advantages in the field of global tumor early screening.

△ company visit

▽

CEIBS Alumni Association Hubei Branch Alumni - Zhang Lianglu

Dr. Zhang Lianglu, General Manager and Chairman of Wuhan Emerson Life Technology Co., Ltd. graduated from Wuhan University, studied at Harvard Business School and China Europe Business School, and is currently the executive director of Hubei Young Entrepreneurs Association and the director of Hubei Provincial Society for Clinical Evaluation of Drugs and Medical Devices , Member of the Gastric Cancer Marker Collaboration Group of the China Anti-Cancer Association, member of the Molecular Diagnosis Expert Committee, Deputy Director of the Science Popularization and Teaching Committee of the Hubei Society of Immunology, and was awarded the leading talent of the Ministry of Industry and Information Technology, Optics Valley 3351 Entrepreneurial Talent, Hubei Young Talent, and Changjiang Student Talent and many other honorary titles.

武汉艾米森生命科技有限公司

武汉艾米森生命科技有限公司成立于2015年1月，是一家专注于全球高发恶性肿瘤早期无创检测产品研发、注册、生产及销售的高新技术企业，公司致力于癌症早诊技术产品的全球化推广，结合表观遗传学、生物信息学、临床大数据和人工智能分析，秉持“早期、精准、便捷、普惠”的产品理念，开创构建了新一代肿瘤筛查检测技术平台和筛查产品体系，领先推出了涵盖消化系统肿瘤、妇科肿瘤、泌尿系统肿瘤与泛癌种等一系列高发肿瘤的早期无创检测产品，真正实现了肿瘤早期、无创、精准检测，从根本上降低了肿瘤的发病率和死亡率，将癌症扼杀于萌芽，为人类生命健康保驾护航。